30-06-2024 12:59 PM | Source: Sushil Financial
BUY VENUS REMEDIES LTD. For Target Rs. 388 - Sushil Financial
We had re-instated coverage on Venus Remedies Ltd. with a BUY rating on March 28, 2024 at Rs.310 for a target price of Rs.388 With the recent run-up in the share price, we change the rating to neutral and close our coverage on the company. At the day’s high of Rs.384, the stock has generated ~24% returns from our recommendation.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report &
Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read
disclaimer before referring below views. Click Here For Disclaimer
Latest News
Centre launches portal for nurturing skill developme...
Hyundai, Kia`s Europe sales down 7.5 pc in October
AI-powered voice analysis may revolutionise early di...
Rohit Sharma to join Indian team in Australia on Sunday
Evening Roundup : A Daily Report on Bullion Energy &...
Buy Copper Above 825 SL Below 821 TGT 830/833 - Axis...
Over 9 in 10 Indian leaders anticipate an increase i...
Evening Track : Renewed Geopolitical uncertainty fue...
Mahayuti government is going to be formed: Shiv Sena...
Everything will get clear on the 23rd: BJPs Rahul Na...